Dr. Shiliang Hu, Ph.D.

Senior Scientist, Genomic Medicine Department at Alexion Pharmaceuticals

Speaker

Senior Scientist with expertise in AAV gene therapy, capsid engineering, and molecular biology. At Alexion-AstraZeneca, I lead the development of innovative gene therapies for rare diseases. Skilled in vector design, transduction efficiency, and immune response management, I drive cross-functional projects and mentor junior scientists. My work focuses on advancing genomic medicine through scalable gene therapy platforms and effective collaboration. Ph.D. in Biomolecular Sciences with a strong publication and patent record.